Takeda (TAK) – Accesswire
-
Takeda and Protagonist Therapeutics, Inc. Enter into Worldwide License and Collaboration Agreement for Rusfertide, a Late-Stage Rare Hematology Asset
-
Moderna and Takeda Announce Plans to Transfer Marketing Authorization for Spikevax(TM) COVID-19 Vaccine in Japan to Moderna
-
Evotec and Takeda Enter Strategic RNA Targeting Drug Discovery and Development Alliance
Back to TAK Stock Lookup